iBio, Inc.

Filed a patent for "high-efficiency, conditionally-activated antibody discovery and masked antibodies" on Fri, August 25, 2023

Filed a patent for "trop2 antibodies" on Mon, June 5, 2023

Filed a patent for "trop2 antibodies" on Tue, July 25, 2023

Filed a patent for "anti-cd3 antibodies" on Fri, March 31, 2023

Filed a patent for "anti-cd3 antibodies" on Thu, October 3, 2024

Filed a patent for "anti-muc16 antibodies" on Mon, February 6, 2023

Filed a patent for "anti-muc16 antibodies" on Thu, August 8, 2024

Filed a patent for "machine learning method for protein modelling to design engineered peptides" on Thu, March 30, 2023

Filed a patent for "epidermal growth factor receptor variant iii antibodies" on Tue, October 11, 2022

Filed a patent for "chemokine receptor 8 (ccr8) antibodies" on Wed, October 19, 2022

Filed a patent for "generalized scaffolds for polypeptide display and uses thereof" on Thu, March 21, 2024

Filed a patent for "pd-1 agonist antibodies" on Tue, July 25, 2023

Filed a patent for "epidermal growth factor receptor variant iii antibodies" on Tue, July 25, 2023

Filed a patent for "chemokine receptor 8 (ccr8) antibodies" on Fri, August 11, 2023

Filed a patent for "pd-1 agonist antibodies" on Thu, March 21, 2024

Filed a patent for "epidermal growth factor receptor variant iii antibodies" on Thu, April 11, 2024

Filed a patent for "chemokine receptor 8 (ccr8) antibodies" on Thu, April 25, 2024

Filed a patent for "pd-1 agonist antibodies" on Wed, September 14, 2022

Filed a patent for "sars-cov-2 subunit and variant vaccines" on Thu, November 24, 2022

Filed a patent for "anti-cd-25 antibody" on Fri, May 6, 2022

Filed a patent for "anti-cd-25 antibody" on Thu, May 25, 2023